Fig. 2.

Effects of NRAL on HCC phenotypes resistant to cisplatin. (a) qRT-PCR was performed to analyse the expression levels of NRAL in HCC cell lines after transfection with pshR-NRAL and pcDNA-NRAL plasmids. **p < 0.01, ***p < 0.001 vs the NC or pcDNA group. (b-c) Cell viability inhibition was assessed by CCK-8 assays in HCC cell lines transfected with pshR1+3-NRAL or pcDNA-NRAL plasmids; rescue experiments were also performed in pshR-NRAL plus ASO miR-340-5p or pcDNA-NRAL plus miR-340-5p plasmid groups. *p < 0.05 vs the NC group, ^#p < 0.05